Shares of Israel Chemicals Ltd (NYSE:ICL) have received an average rating of “Hold” from the six research firms that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $5.91.
ICL has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Wednesday, August 29th. Jefferies Financial Group reaffirmed a “hold” rating and set a $6.57 target price on shares of Israel Chemicals in a research note on Sunday, October 21st. BMO Capital Markets reaffirmed a “hold” rating and set a $5.25 target price on shares of Israel Chemicals in a research note on Wednesday, September 19th. Finally, ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research note on Friday, August 24th.
ICL traded up $0.06 during trading on Thursday, hitting $5.95. The stock had a trading volume of 154,845 shares, compared to its average volume of 202,150. The company has a market cap of $7.67 billion, a price-to-earnings ratio of 19.19, a price-to-earnings-growth ratio of 1.68 and a beta of 1.07. Israel Chemicals has a twelve month low of $3.85 and a twelve month high of $6.90. The company has a quick ratio of 0.73, a current ratio of 1.34 and a debt-to-equity ratio of 0.44.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Tuesday, December 4th will be paid a dividend of $0.051 per share. The ex-dividend date is Monday, December 3rd. This is an increase from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 dividend on an annualized basis and a yield of 3.43%. Israel Chemicals’s payout ratio is 32.26%.
A number of hedge funds have recently modified their holdings of the business. Artemis Investment Management LLP acquired a new stake in Israel Chemicals in the 3rd quarter valued at about $49,871,000. FMR LLC purchased a new stake in shares of Israel Chemicals during the third quarter valued at approximately $25,668,000. Altshuler Shaham Ltd raised its stake in shares of Israel Chemicals by 441.5% during the third quarter. Altshuler Shaham Ltd now owns 1,370,810 shares of the basic materials company’s stock valued at $8,390,000 after purchasing an additional 1,117,665 shares during the period. Allianz Asset Management GmbH purchased a new stake in shares of Israel Chemicals during the third quarter valued at approximately $4,463,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Israel Chemicals by 2,050.6% during the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 649,982 shares of the basic materials company’s stock valued at $2,990,000 after purchasing an additional 619,759 shares during the period. 9.16% of the stock is currently owned by institutional investors.
About Israel Chemicals
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Further Reading: Tariff
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.